Literature DB >> 8395074

Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.

D L Rudolph1, J Yee, T Palker, J E Coligan, R B Lal.   

Abstract

Synthetic peptides derived from the env protein of human T-lymphotropic virus type I (HTLV-I) were used to identify the immunodominant motifs in rhesus macaques naturally infected with simian T-lymphotropic virus type I (STLV-I). Of the 13 peptides derived from the env protein of HTLV-I, Env-1(191-214) and Env-5(242-257) reacted with 81% (44/54) and 54% (29/54) of specimens from infected monkeys, respectively. A recombinant protein (MTA-I162-209) reacted with 53 of 54 (98%) STLV-I-infected serum specimens. While similar immune reactivities to Env-1 and MTA-1 were observed in both HTLV-I-infected human sera and STLV-I-infected monkey sera, the reactivity to Env-5 was significantly higher in HTLV-I-infected human sera. Differential reactivities may be attributed to the differences in the secondary structures of the STLV-I and HTLV-I envelope protein in the Env-5 region, since homologous peptide with STLV-I sequence did not result in enhanced sensitivity of anti-Env-5 antibody detection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395074     DOI: 10.1016/s0923-2516(06)80029-4

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  2 in total

1.  APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.

Authors:  Marcel Ooms; Aikaterini Krikoni; Andrea K Kress; Viviana Simon; Carsten Münk
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

Review 2.  Specific pathogen free macaque colonies: a review of principles and recent advances for viral testing and colony management.

Authors:  JoAnn L Yee; Thomas H Vanderford; Elizabeth S Didier; Stanton Gray; Anne Lewis; Jeffrey Roberts; Kerry Taylor; Rudolf P Bohm
Journal:  J Med Primatol       Date:  2016-03-01       Impact factor: 0.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.